Lenalidomide leads the way in 3 European countries.
In: PharmacoEconomics & Outcomes News, 2012-06-23, Heft 656, S. 6-6
serialPeriodical
Zugriff:
The article discusses 3 European studies presented at the 17th Annual International Meeting of the International Society of Pharmacoeconomics and Outcomes Research which shows the cost-effectiveness of lenalidomide, in combination with dexamethasone, in previously treated patients with multiple myeloma.
Titel: |
Lenalidomide leads the way in 3 European countries.
|
---|---|
Zeitschrift: | PharmacoEconomics & Outcomes News, 2012-06-23, Heft 656, S. 6-6 |
Veröffentlichung: | 2012 |
Medientyp: | serialPeriodical |
ISSN: | 1173-5503 (print) |
DOI: | 10.2165/00151234-201206560-00007 |
Schlagwort: |
|
Sonstiges: |
|